HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catheter-directed therapy for acute pulmonary embolism: results of a multicenter national registry.

AbstractINTRODUCTION AND OBJECTIVES:
Catheter-directed therapy (CDT) for acute pulmonary embolism (PE) is an emerging therapy that combines heterogeneous techniques. The aim of the study was to provide a nationwide contemporary snapshot of clinical practice and CDT-related outcomes.
METHODS:
This Investigator-initiated multicenter registry aimed to include consecutive patients with intermediate-high risk (IHR) or high-risk (HR), acute PE eligible for CDT. The primary outcome of the study was in-hospital all-cause death.
RESULTS:
A total of 253 patients were included, of whom 93 (36.8%) had HR-PE, and 160 (63.2%) had IHR-PE with a mean age of 62.3±15.1 years. Local thrombolysis was performed in 70.8% and aspiration thrombectomy in 51.8%, with 23.3% of patients receiving both. However, aspiration thrombectomy was favored in the HR-PE cohort (80.6% vs 35%; P<.001). Only 51 patients (20.2%) underwent CDT with specific PE devices. The success rate for CDT was 90.9% (98.1% of IHR-PE patients vs 78.5% of HR-PE patients, P<.001). In-hospital mortality was 15.5%, and was highly concentrated in the HR-PE patients (37.6%) and significantly lower in IHR-PE patients (2.5%), P<.001. Long-term (24-month) mortality was 40.2% in HR-PE patients vs 8.2% in IHR-PE patients (P<.001).
CONCLUSIONS:
Despite the high success rate for CDT, in-hospital mortality in HR-PE is still high (37.6%) compared with very low IHR-PE mortality (2.5%).
AuthorsPablo Salinas, María-Eugenia Vázquez-Álvarez, Neus Salvatella, Valeriano Ruiz Quevedo, Maite Velázquez Martín, Ernesto Valero, Eva Rumiz, Alfonso Jurado-Román, Íñigo Lozano, Fernando Gallardo, Ignacio J Amat-Santos, Óscar Lorenzo, Juan José Portero Portaz, Mike Huanca, Luis Nombela-Franco, Beatriz Vaquerizo, Raúl Ramallal Martínez, Nicolás Manuel Maneiro Melón, Juan Sanchis, Alberto Berenguer, Arsenio Gallardo-López, Enrique Gutiérrez-Ibañes, Hernán Mejía-Rentería, Juan Gabriel Córdoba-Soriano, Jesús María Jiménez-Mazuecos
JournalRevista espanola de cardiologia (English ed.) (Rev Esp Cardiol (Engl Ed)) Vol. 77 Issue 2 Pg. 138-147 (Feb 2024) ISSN: 1885-5857 [Electronic] Spain
PMID37354942 (Publication Type: Multicenter Study, Journal Article)
CopyrightCopyright © 2023 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.
Chemical References
  • Fibrinolytic Agents
Topics
  • Humans
  • Middle Aged
  • Aged
  • Fibrinolytic Agents (therapeutic use)
  • Thrombolytic Therapy (methods)
  • Treatment Outcome
  • Pulmonary Embolism (therapy)
  • Thrombectomy (methods)
  • Catheters
  • Registries
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: